Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Myopia is a common visual disorder with increasing prevalence. Halting progression of myopia is critical, as high myopia can be complicated by a number of vision-compromising conditions. METHODS: Literature search was conducted in the following databases: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), Cochrane Database of Systematic Reviews (CDSR), Database of Abstracts of Reviews of Effects (DARE) and Centre for Reviews and Dissemination (CRD) Health Technology Assessment (HTA) database. Systematic reviews and meta-analyses investigating the efficacy and safety of multiple myopia interventions vs control conditions, were considered. Methodological quality and quality of evidence of eligible studies were assessed using the ROBIS tool and GRADE rating. The degree of overlapping of index publications in the eligible reviews was calculated with the corrected covered area (CCA). RESULTS: Forty-four unique primary studies contained in 18 eligible reviews and involving 6400 children were included in the analysis. CCA was estimated as 6.2% and thus considered moderate. Results demonstrated the superior efficacy of atropine eyedrops; 1% atropine vs placebo (change in refraction: -0.78D, [- 1.30 to - 0.25] in 1 year), 0.025 to 0.05% atropine vs control (change in refraction: -0.51D, [- 0.60 to - 0.41] in 1 year), 0.01% atropine vs control (change in refraction: -0.50D, [- 0.76 to - 0.24] in 1 year). Atropine was followed by orthokeratology (axial elongation: - 0.19 mm, [- 0.21 to - 0.16] in 1 year) and novel multifocal soft contact lenses (change in refraction: -0.15D, [- 0.27 to - 0.03] in 1 year). As regards adverse events, 1% atropine induced blurred near vision (odds ratio [OR] 9.47, [1.17 to 76.78]) and hypersensitivity reactions (OR 8.91, [1.04 to 76.03]). CONCLUSIONS: Existing evidence has failed to convince doctors to uniformly embrace treatments for myopic progression control, possibly due to existence of some heterogeneity, reporting of side effects and lack of long-term follow-up. Research geared towards efficient interventions is still necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since overlap was estimated at below 10%, all included reviews were retained in the analysis.”
From Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews (2021) · cites this paper as [24]
In the citing paper
“This overview identified 18 systematic reviews that synthesized the efficacy of a variety of interventions for myopia from 44 unique primary studies (1989–2016).”
From Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews (2021) · cites this paper as [24]
In the citing paper
“Overlap was considered moderate in this overview and was estimated at 6.2% using the CCA method.”
From Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
ROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272
Systematic review finds overlapping reviews were not mentioned in every other overview
Pieper, D., Antoine, S.-L., Mathes, T., Neugebauer, E. A. M., & Eikermann, M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.007 · Cited by 1,318
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291
Efficacy Comparison of 16 Interventions for Myopia Control in Children
Huang, J., Wen, D., Wang, Q., McAlinden, C., Flitcroft, I., Chen, H., Saw, S. M., Chen, H., Bao, F., Zhao, Y., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.11.010 · Cited by 752
Low-Concentration Atropine for Myopia Progression (LAMP) Study
Yam, J. C., Jiang, Y., Tang, S. M., Law, A. K. P., Chan, J. J., Wong, E., Ko, S. T., Young, A. L., Tham, C. C., Chen, L. J., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.029 · Cited by 724
Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2
Chia, A., Lu, Q.-S., & Tan, D. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.07.004 · Cited by 649
Xiong, S., Sankaridurg, P., Naduvilath, T., Zang, J., Zou, H., Zhu, J., Lv, M., He, X., & Xu, X. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13403 · Cited by 617
Research works printed but not linked: 2
- Becker LA, Oxman AD. Chapter 22: overviews of reviews. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). The Cochrane Collaboration; 2011. In: Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley, Ltd; 2011. p. 607–31. Available from: http://doi.wiley.com/10.1002/9780470712184.ch22 . · DOI · Paper page
- Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. The Oxford 2011 levels of evidence. Oxford Centre evidence-based medicine, vol. 1; 2011. Group. Available from: http://www.cebm.net/index.aspx?o=1025
Cited by
Brennan, N. A., Toubouti, Y. M., Cheng, X., & Bullimore, M. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100923 · Cited by 355
Lunny, C., Pieper, D., Thabet, P., & Kanji, S. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01269-y · Cited by 252
Biological Mechanisms of Atropine Control of Myopia
Upadhyay, A., & Beuerman, R. W. (2020) · Eye & Contact Lens: Science & Clinical Practice · doi:10.1097/icl.0000000000000677 · Cited by 186
Nucci, P., Lembo, A., Schiavetti, I., Shah, R., Edgar, D. F., & Evans, B. J. W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281816 · Cited by 144
Choroidal thickness and ocular growth in childhood
Prousali, E., Δαστιρίδου, Ά., Ziakas, N. G., Androudi, S. N., & Mataftsi, A. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.06.008 · Cited by 98
Self-citation
Metadata
- Authors
- Prousali, E., Haidich, A.-B., Fontalis, A., Ziakas, N., Brazitikos, P., & Mataftsi, A.
- Affiliations
- Aristotle University of Thessaloniki (GR)
- Corresponding author
- Mataftsi, Asimina
- Venue
- BMC Ophthalmology
- Published
- 2019-05-09
- Volume
- 19
- Issue
- 1
- Pages
- 106-106
- ISSN
- 1471-2415 (ISSN-L)
- PMC
- PMC6506938
- OpenAlex
- W2943981724
- Cited by
- 75
- References
- 60
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 3 · 2023: 14 · 2022: 9 · 2021: 17 · 2020: 11
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Ophthalmology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- State Scholarships Foundation (2018-050-0502-12431)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Social Sciences › Human Factors and Ergonomics › Ergonomics and Musculoskeletal Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- myopia progression, myopia control, children, atropine eye drops, orthokeratology, multifocal soft contact lenses, adverse events, hypersensitivity, axial elongation, systematic reviews and meta-analyses, publication bias
- MeSH terms
- Child, Contact Lenses, Hydrophilic, Eyeglasses, Humans, Mydriatics, Disease Progression, Risk Reduction Behavior, Myopia, Degenerative
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses. https://app.cochat.ai/papers/10.1186/s12886-019-1112-3
- The paper
- Prousali, E., Haidich, A.-B., Fontalis, A., Ziakas, N., Brazitikos, P., & Mataftsi, A. (2019). Efficacy and safety of interventions to control myopia progression in children: an overview of systematic reviews and meta-analyses. BMC Ophthalmology. https://doi.org/10.1186/s12886-019-1112-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.